Business Context and Reporting Period
This Form 8-K is filed by BioSig Technologies, Inc. (not Streamex Corp.) with a report date of November 29, 2019. The company is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The filing reports on a material definitive agreement entered into on the report date and a subsequent press release issued on December 3, 2019.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate events rather than financial performance data.
Material Changes and Agreements
- Consulting Agreement: On November 29, 2019, the Company entered into a consulting agreement with Reified Capital, LLC.
- Terms: Reified Capital will provide consulting services in exchange for a monthly fee. The term is one year with automatic renewal for successive one-year terms.
- Termination: Either party may terminate the agreement with 60 days of prior written notice.
- Technical Collaboration: A press release dated December 3, 2019, announced a technical collaboration with Reified Capital, incorporated by reference as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the standard nature of entering into a new contractual agreement. No unusual items or contingencies are disclosed in the text provided.
Investor Verification Checklist
- Verify the exact amount of the monthly consulting fee payable to Reified Capital, LLC, as the filing text does not disclose the specific figure.
- Review the full text of the press release (Exhibit 99.1) to understand the scope of the "technical collaboration" mentioned.
- Confirm the impact of this agreement on the company's operating expenses in future quarterly reports.
- Note the discrepancy between the requested company name (Streamex Corp.) and the actual registrant (BioSig Technologies, Inc.).